Clinical trial
The Surpass Intracranial Aneurysm Embolization System Pivotal Trial to Treat Large or Giant Wide Neck Aneurysms (SCENT Trial)
NCT01716117 is registered in ClinicalTrials.gov with Stryker Neurovascular as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Surpass Intracranial Aneurysm Embolization System Pivotal Trial to Treat Large or Giant Wide Neck Aneurysms (SCENT Trial)
- Lead sponsor
- Stryker Neurovascular
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 25, 2012
- Completion date
- July 7, 2022
- Enrollment
- 213 (actual)
- Sites
- 26
Conditions
As the registry lists them; a condition with its own page is linked.
brain aneurysm